David S. Kabakoff's Insider Trades & SAST Disclosures
David S. Kabakoff's most recent trade in Nextcure Inc was a trade of 28,050 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 20, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern David S. Kabakoff.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Nextcure Inc | David S. Kabakoff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 28,050 | 28,050 | - | - | Stock Option (Right to Buy) | |
| Nextcure Inc | David S. Kabakoff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2021 | 14,250 | 14,250 | - | - | Stock Option (Right to Buy) | |
| Castle Biosciences Inc | David S. Kabakoff | Director | Sale of securities on an exchange or to another person at price $ 75.07 per share. | 17 Jun 2021 | 30,000 | 503,577 (2%) | 0% | 75.1 | 2,252,088 | Common Stock |
| Castle Biosciences Inc | David S. Kabakoff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2021 | 3,379 | 3,379 | - | - | Stock option (right to buy) | |
| Castle Biosciences Inc | David S. Kabakoff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2021 | 830 | 830 | - | - | Restricted Stock Units | |
| Castle Biosciences Inc | David S. Kabakoff | Director | Sale of securities on an exchange or to another person at price $ 71.79 per share. | 05 Apr 2021 | 50,000 | 593,577 (3%) | 0% | 71.8 | 3,589,600 | Common Stock |
| Castle Biosciences Inc | David S. Kabakoff | Director | Sale of securities on an exchange or to another person at price $ 73.99 per share. | 05 Apr 2021 | 40,000 | 533,577 (3%) | 0% | 74.0 | 2,959,708 | Common Stock |
| Castle Biosciences Inc | David S. Kabakoff | Director | Sale of securities on an exchange or to another person at price $ 73.22 per share. | 05 Apr 2021 | 20,000 | 573,577 (3%) | 0% | 73.2 | 1,464,422 | Common Stock |
| Castle Biosciences Inc | David S. Kabakoff | Director | Sale of securities on an exchange or to another person at price $ 70.00 per share. | 31 Mar 2021 | 40,000 | 663,577 (3%) | 0% | 70.0 | 2,800,052 | Common Stock |
| Castle Biosciences Inc | David S. Kabakoff | Director | Sale of securities on an exchange or to another person at price $ 70.80 per share. | 31 Mar 2021 | 20,000 | 643,577 (3%) | 0% | 70.8 | 1,416,034 | Common Stock |
| Castle Biosciences Inc | David S. Kabakoff | Director | Sale of securities on an exchange or to another person at price $ 67.56 per share. | 31 Mar 2021 | 20,000 | 713,577 (4%) | 0% | 67.6 | 1,351,252 | Common Stock |
| Castle Biosciences Inc | David S. Kabakoff | Director | Sale of securities on an exchange or to another person at price $ 68.15 per share. | 31 Mar 2021 | 10,000 | 703,577 (4%) | 0% | 68.2 | 681,545 | Common Stock |
| Castle Biosciences Inc | David S. Kabakoff | Director | Sale of securities on an exchange or to another person at price $ 67.12 per share. | 19 Mar 2021 | 10,000 | 733,577 (4%) | 0% | 67.1 | 671,212 | Common Stock |
| Castle Biosciences Inc | David S. Kabakoff | Director | Sale of securities on an exchange or to another person at price $ 66.17 per share. | 19 Mar 2021 | 10,000 | 743,577 (4%) | 0% | 66.2 | 661,699 | Common Stock |
| Castle Biosciences Inc | David S. Kabakoff | Director | Sale of securities on an exchange or to another person at price $ 64.63 per share. | 16 Mar 2021 | 40,000 | 783,577 (4%) | 0% | 64.6 | 2,585,056 | Common Stock |
| Castle Biosciences Inc | David S. Kabakoff | Director | Sale of securities on an exchange or to another person at price $ 61.21 per share. | 16 Mar 2021 | 30,000 | 853,577 (4%) | 0% | 61.2 | 1,836,351 | Common Stock |
| Castle Biosciences Inc | David S. Kabakoff | Director | Sale of securities on an exchange or to another person at price $ 63.76 per share. | 16 Mar 2021 | 30,000 | 823,577 (4%) | 0% | 63.8 | 1,912,707 | Common Stock |
| Castle Biosciences Inc | David S. Kabakoff | Director | Sale of securities on an exchange or to another person at price $ 65.73 per share. | 16 Mar 2021 | 20,000 | 763,577 (4%) | 0% | 65.7 | 1,314,566 | Common Stock |
| Castle Biosciences Inc | David S. Kabakoff | Director | Sale of securities on an exchange or to another person at price $ 66.14 per share. | 16 Mar 2021 | 10,000 | 753,577 (4%) | 0% | 66.1 | 661,365 | Common Stock |
| Castle Biosciences Inc | David S. Kabakoff | Director | Sale of securities on an exchange or to another person at price $ 54.16 per share. | 08 Oct 2020 | 25,000 | 883,577 (5%) | 0% | 54.2 | 1,354,075 | Common Stock |
| Castle Biosciences Inc | David S. Kabakoff | Director | Sale of securities on an exchange or to another person at price $ 54.23 per share. | 08 Oct 2020 | 25,000 | 908,577 (5%) | 0% | 54.2 | 1,355,778 | Common Stock |
| Castle Biosciences Inc | David S. Kabakoff | Director | Sale of securities on an exchange or to another person at price $ 53.09 per share. | 06 Oct 2020 | 50,000 | 933,577 (5%) | 0% | 53.1 | 2,654,655 | Common Stock |
| Castle Biosciences Inc | David S. Kabakoff | Director | Sale of securities on an exchange or to another person at price $ 52.09 per share. | 02 Oct 2020 | 25,000 | 983,577 (5%) | 0% | 52.1 | 1,302,250 | Common Stock |
| Castle Biosciences Inc | David S. Kabakoff | Director | Sale of securities on an exchange or to another person at price $ 52.07 per share. | 02 Oct 2020 | 25,000 | 1,008,577 (5%) | 0% | 52.1 | 1,301,683 | Common Stock |
| Castle Biosciences Inc | David S. Kabakoff | Director | Sale of securities on an exchange or to another person at price $ 46.05 per share. | 03 Sep 2020 | 25,000 | 1,033,577 (6%) | 0% | 46.1 | 1,151,325 | Common Stock |
| Castle Biosciences Inc | David S. Kabakoff | Director | Sale of securities on an exchange or to another person at price $ 44.78 per share. | 19 Aug 2020 | 75,000 | 1,058,577 (6%) | 0% | 44.8 | 3,358,500 | Common Stock |
| Castle Biosciences Inc | David S. Kabakoff | Director | Sale of securities on an exchange or to another person at price $ 42.01 per share. | 10 Aug 2020 | 25,000 | 1,133,577 (6%) | 0% | 42.0 | 1,050,305 | Common Stock |
| Castle Biosciences Inc | David S. Kabakoff | Director | Sale of securities on an exchange or to another person at price $ 43.04 per share. | 17 Jul 2020 | 25,000 | 1,158,577 (6%) | 0% | 43.0 | 1,075,900 | Common Stock |
| Castle Biosciences Inc | David S. Kabakoff | Director | Sale of securities on an exchange or to another person at price $ 43.60 per share. | 09 Jul 2020 | 50,000 | 1,183,577 (6%) | 0% | 43.6 | 2,180,185 | Common Stock |
| Castle Biosciences Inc | David S. Kabakoff | Director | Sale of securities on an exchange or to another person at price $ 40.38 per share. | 22 Jun 2020 | 150,000 | 1,283,577 (7%) | 0% | 40.4 | 6,057,135 | Common Stock |
| Castle Biosciences Inc | David S. Kabakoff | Director | Sale of securities on an exchange or to another person at price $ 42.13 per share. | 22 Jun 2020 | 25,000 | 1,233,577 (7%) | 0% | 42.1 | 1,053,373 | Common Stock |
| Castle Biosciences Inc | David S. Kabakoff | Director | Sale of securities on an exchange or to another person at price $ 41.23 per share. | 22 Jun 2020 | 25,000 | 1,258,577 (7%) | 0% | 41.2 | 1,030,863 | Common Stock |
| Nextcure Inc | David S. Kabakoff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2020 | 14,250 | 14,250 | - | - | Stock Option (Right to Buy) | |
| Castle Biosciences Inc | David S. Kabakoff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2020 | 8,000 | 8,000 | - | - | Stock option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges